Commonly-prescribed SSRI antidepressants should be given to pregnant women with “great caution” because the drugs could raise risk for miscarriage, premature birth and health problems in both mom and a newborn baby, a new study concludes. Alice Domar, HMS assistant clinical professor of obstetrics, gynecology and reproductive biology at Beth Israel Deaconess Medical Center, is a co-author of the study.
